156 related articles for article (PubMed ID: 3276492)
21. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
[TBL] [Abstract][Full Text] [Related]
22. Thymopentine treatment improves clinical and immunological functions in aged subjects with chronic bronchitis.
Pavoni D; Crosti F; Ciboddo GF; Sabbadini MG; Baldini V; Navone P; Bellone M; Rugarli C
Boll Ist Sieroter Milan; 1987; 66(4):308-15. PubMed ID: 3327513
[TBL] [Abstract][Full Text] [Related]
23. [Use of thymopentin in the treatment of post-radiation cystitis].
Martinoli F; Catania G; Bertana F; Caldera G
Minerva Urol Nefrol; 1988; 40(4):275-6. PubMed ID: 3075095
[No Abstract] [Full Text] [Related]
24. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
Faist E; Riedel A; Bolla K
Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
[TBL] [Abstract][Full Text] [Related]
25. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.
Bolla K; Djawari D; Kokoschka EM; Petres J; Lidén S; Gonseth R; Amblard P; Bernengo MG; Bonerandi JJ; Claudy A
Surv Immunol Res; 1985; 4 Suppl 1():37-47. PubMed ID: 3898291
[TBL] [Abstract][Full Text] [Related]
26. Thymopentin therapy reduces the clinical severity of atopic dermatitis.
Leung DY; Hirsch RL; Schneider L; Moody C; Takaoka R; Li SH; Meyerson LA; Mariam SG; Goldstein G; Hanifin JM
J Allergy Clin Immunol; 1990 May; 85(5):927-33. PubMed ID: 2185294
[TBL] [Abstract][Full Text] [Related]
27. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296
[TBL] [Abstract][Full Text] [Related]
28. [Thymopentin and immune response in patients with cancer].
Petronella P; Ferrone R; Freda F; Valeriani G
Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
[TBL] [Abstract][Full Text] [Related]
29. [Thymopentin in the treatment of cutaneous melanoma].
Trevisan G; Agolzer A
G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
[TBL] [Abstract][Full Text] [Related]
30. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
[No Abstract] [Full Text] [Related]
31. Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.
Franchimont P; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():70-5. PubMed ID: 3898295
[TBL] [Abstract][Full Text] [Related]
32. An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis.
Giordano N; Biasi G; Taddeo A; Marcolongo R; Bertelletti D
Clin Rheumatol; 1989 Jun; 8(2):293-4. PubMed ID: 2667863
[No Abstract] [Full Text] [Related]
33. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
[TBL] [Abstract][Full Text] [Related]
34. [Prospects in the treatment of rheumatoid polyarthritis].
Crouzet J
Rev Rhum Mal Osteoartic; 1988 Apr; 55(6):472-4. PubMed ID: 3134690
[TBL] [Abstract][Full Text] [Related]
35. [Therapy of recurrent oral aphthae with thymopoetin pentapeptide].
Djawari D; Haneke E
Hautarzt; 1983 Sep; 34(9):463-4. PubMed ID: 6355012
[TBL] [Abstract][Full Text] [Related]
36. Normalization of the CD4/CD8 lymphocyte ratio and increased B lymphocytes in long standing diabetic patients following therapy with thymopentin.
Pozzilli P; Visalli N; Cavallo MG; Beales P; Negri M; Ghirlanda G; Papa V; Andreani D
Diabetes Res; 1987 Oct; 6(2):51-6. PubMed ID: 2962799
[TBL] [Abstract][Full Text] [Related]
37. Thymopentin treatment in genital warts of long duration.
Fransen L; Anthoons J; Hoogewijs G; Bolla K
Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
[TBL] [Abstract][Full Text] [Related]
38. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
Hamilton G; Zöch G; Rath T; Meissl G
Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
[No Abstract] [Full Text] [Related]
39. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
[TBL] [Abstract][Full Text] [Related]
40. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
